---
title: "Bambusa Therapeutics hits 52-week high in regular trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305186379.md"
description: "Bambusa Therapeutics rose 3.53% to $17.65 during regular trading, hitting a 52-week high intraday."
datetime: "2026-11-11T15:04:37.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305186379.md)
  - [en](https://longbridge.com/en/news/305186379.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305186379.md)
generator: "portal-rs"
---

# Bambusa Therapeutics hits 52-week high in regular trading

Bambusa Therapeutics (BBTX.US) climbed nearly **4%** during regular trading to **$17.65**, hitting a 52-week high intraday.

The company recently completed an oversubscribed initial public offering at the midpoint price of **$16** per share, selling **10.6 million** shares to raise **$169 million**.

Based on public media reports. AI-generated; not investment advice.

### Related Stocks

- [BBTX.US](https://longbridge.com/en/quote/BBTX.US.md)

## Related News & Research

- [Bambusa Therapeutics Director Helmut Wolfgang Jeggle Reports $6 Million Common Share Acquisition](https://longbridge.com/en/news/304008064.md)
- [Peter Kolchinsky and Rajeev Shah Disclose 14.6% Stake in Bambusa Therapeutics](https://longbridge.com/en/news/304691682.md)
- [Is ServiceNow (NOW) Trading At Too High A Premium For Earnings?](https://longbridge.com/en/news/306039339.md)
- [BUZZ-Street View: Nvidia's AI story intact despite uncertainty at top](https://longbridge.com/en/news/305945171.md)
- [How did Coinbase stop deepfake Elon Musk’s promise to double your crypto?](https://longbridge.com/en/news/306049317.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**